Nehad M Ayoub Selected Research

Nehad M Ayoub Research Topics

Disease

29	Neoplasms (Cancer) 01/2024 - 01/2011
23	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2011
2	Triple Negative Breast Neoplasms 01/2024 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2014
2	Granulomatous Mastitis 01/2020 - 03/2019
2	Carcinogenesis 01/2017 - 01/2015
2	Hodgkin Disease (Hodgkin's Disease) 10/2016 - 10/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022
1	Cancer Pain 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2020
1	Hypercholesterolemia 01/2020
1	Exanthema (Rash) 01/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 07/2019
1	Pain (Aches) 07/2019
1	Inflammation (Inflammations) 03/2019
1	Abscess 03/2019
1	Pathologic Neovascularization 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 11/2018
1	Cachexia 04/2017
1	Anorexia 04/2017
1	Hematologic Neoplasms (Hematological Malignancy) 07/2016
1	Atherosclerosis 05/2016
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2016
1	Multiple Myeloma 10/2015

Drug/Important Bio-Agent (IBA)

6	TocotrienolsIBA 05/2014 - 01/2011
5	Hormones (Hormone)IBA 01/2022 - 09/2017
4	Estrogen ReceptorsIBA 01/2021 - 09/2017
4	oleocanthalIBA 05/2019 - 01/2014
3	Phosphotransferases (Kinase)IBA 01/2024 - 01/2015
3	Tyrosine Kinase InhibitorsIBA 12/2022 - 02/2019
3	CrizotinibIBA 01/2021 - 01/2017
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2016
3	Olive OilIBA 02/2019 - 01/2014
2	tyrosine receptor (receptor, tyrosine)IBA 01/2024 - 01/2015
2	human ERBB2 proteinIBA 01/2022 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2019
2	Immunoglobulin M (IgM)IBA 01/2020 - 03/2019
2	Lapatinib (GW572016)FDA Link 05/2019 - 02/2019
2	ErbB Receptors (EGF Receptor)IBA 02/2019 - 01/2019
2	VaccinesIBA 01/2019 - 01/2014
2	tremortin (penitrem A)IBA 05/2018 - 01/2013
2	MitogensIBA 09/2017 - 09/2013
2	Tocopherols (Tocopherol)IBA 01/2014 - 01/2011
2	sesaminIBA 01/2013 - 11/2012
1	capmatinibIBA 12/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	B7-H1 AntigenIBA 01/2021
1	ParaffinIBA 01/2021
1	pseurotinIBA 01/2020
1	LDL Receptors (LDL Receptor)IBA 01/2020
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2020
1	4- azido- 7- phenylpyrazolo- (1,5a)- 1,3,5- triazineIBA 07/2019
1	Cadherins (E-Cadherin)IBA 05/2019
1	Proteins (Proteins, Gene)FDA Link 05/2019
1	VimentinIBA 05/2019
1	Focal Adhesion Protein-Tyrosine KinasesIBA 02/2019
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 02/2019
1	PaxillinIBA 02/2019
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2019
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2019
1	Lactoylglutathione LyaseIBA 01/2019
1	EnzymesIBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 05/2018
1	Phenobarbital (Luminal)FDA Link 09/2017
1	Tamoxifen FDA LinkGeneric 09/2017
1	Brentuximab VedotinIBA 10/2016
1	Immunoconjugates (Immunoconjugate)IBA 10/2016
1	Alkylating AgentsIBA 10/2016
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 07/2016
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 07/2016
1	LDL Lipoproteins (beta Lipoproteins)IBA 05/2016
1	Syndecan-1 (Syndecan 1)IBA 10/2015
1	araguspongine CIBA 01/2015
1	AlkaloidsIBA 01/2015
1	xestospongin BIBA 01/2015
1	alpha-Tocopherol FDA Link 05/2014
1	MHC class II transactivator proteinIBA 01/2014
1	Interferon-gamma (Interferon, gamma)IBA 01/2014
1	invariant chain (Ii-Key)IBA 01/2014
1	AntioxidantsIBA 01/2014
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2014
1	Antisense OligonucleotidesIBA 01/2014

Therapy/Procedure

17	Therapeutics 01/2022 - 01/2011
7	Drug Therapy (Chemotherapy) 01/2024 - 01/2014
4	Precision Medicine 11/2020 - 10/2015
2	Immunotherapy 01/2019 - 01/2014
1	Pain Management 07/2019
1	Neoadjuvant Therapy 05/2019
1	Radiotherapy 01/2019